Interactions Between Total Nucleated and CD34 Cell Dose and Their Impact on Outcomes After Single and Double Unrelated Cord Blood Transplantation for Patients with Hematological Malignancies. An Analysis on Behalf of Societe' Francaise De Greffe De Moelle Et Therapie Cellulaire (SFGM-TC) and Eurocord

被引：0
|
作者：
Michallet, Mauricette [1 ]
Cunha, Renato L. G. [2 ]
Michel, Gerard [3 ]
Socie, Gerard [2 ]
Mohty, Mohamad [4 ]
Rio, Bernard [5 ]
Blaise, Didier [6 ]
Sirvent, Anne [7 ]
Tabrizzi, Reza [8 ]
Bordigoni, Pierre [9 ]
Deconinck, Eric [10 ]
Yakoubagha, Ibrahim [11 ]
Rossi, Jean-Francois [12 ,13 ]
Maillard, Natacha [14 ]
Sobh, Mohamad [1 ]
Garnier, Federico [15 ]
Ruggeri, Annalisa [2 ]
Gluckman, Eliane [2 ]
Rocha, Vanderson [2 ]
机构：
[1] Hop Edouard Herriot, Lyon, France
[2] Hop St Louis, Paris, France
[3] Hop La Timone, Dept Hematol, Marseille, France
[4] CHU Nantes, Dept Hematol, F-44035 Nantes 01, France
[5] Hop Hotel Dieu, Paris, France
[6] Inst J Paoli I Calmettes, F-13009 Marseille, France
[7] Hop Archet I, Hematol Clin, Nice, France
[8] Hop Haut Leveque, Pessac, France
[9] Hop Brabois, Hop Enfants, Nancy, France
[10] French Belgian Swiss APL Grp, Bobigny, France
[11] Hop Claude Huriez, Serv Hematol, Lille, France
[12] CHU Montpellier, Montpellier, France
[13] INSERM, U847, Montpellier, France
[14] CHU Poitiers, Poitiers CIC 802, INSERM, Paris, France
[15] Agence Biomed, Paris, France
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：163 / 164
页数：2
相关论文
共 50 条
  • [41] Reduced Intensity Conditioning Regimens Do Not Offer a Survival Advantage to Myeloma Patients Receiving Allogeneic Stem Cell Hematopoietic Transplantation: A Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry Study
    Beaussant, Yvan
    Daguindau, Etienne
    Vivot, Aurore
    Mothy, Mohamad
    Avet-Loiseau, Herve
    Roos-Weil, Damien
    Michallet, Mauricette
    Raus, Nicole
    Blaise, Didier
    Vigouroux, Stephane
    Buzyn, Agnes
    Socie, Gerard
    Fegueux, Nathalie
    Garban, Frederic
    Deconinck, Eric
    BLOOD, 2011, 118 (21) : 1757 - 1758
  • [42] Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies:: A 10-year retrospective analysis from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
    Michallet, Mauricette
    Le, Quoc-Hung
    Mohty, Mohamad
    Prebet, Thomas
    Nicolini, Franck
    Boiron, Jean Michel
    Esperou, Helene
    Attal, Michel
    Milpied, Noel
    Lioure, Bruno
    Bordigoni, Pierre
    Yakoub-Agha, Ibrahim
    Bourhis, Jean-Henri
    Rio, Bernard
    Deconinck, Eric
    Renaud, Marc
    Chir, Zina
    Blaise, Didier
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (05) : 535 - 544
  • [43] Reduce-intensity conditioning regimen prior to unrelated cord blood transplantation in patients with acute myeloid leukaemia: a prospective phase II multicentric trial of the Societe Francaise de Greffe de Moelle et Therapie Cellulaire and Eurocord
    Rio, B.
    Chevret, S.
    Vigouroux, S.
    Chevallier, P.
    Furst, S.
    Sirvent, A.
    Bay, J. O.
    Socie, G.
    Ceballos, P.
    Huynh, A.
    Cornillon, J.
    Francois, S.
    Legrand, F.
    Yakoub-Agha, I.
    Gerard, M.
    Maillard, N.
    Margueritte, G.
    Maury, S.
    Uzunov, M.
    Bulabois, C. E.
    Michallet, M.
    Clement, L.
    Dauriac, C.
    Bilger, K.
    Simon, T.
    Gluckman, E.
    Milpied, N.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S10 - S11
  • [44] Total nucleated and CD34 cell dose and their impact on engraftment and NRM after single unrelated cord blood transplantation for patients with haematological malignancies
    Cunha, R.
    Michallet, M.
    Michel, G.
    Socie, G.
    Rio, B.
    Mohty, M.
    Yakoub-Agha, I.
    Sirvent, A.
    Maillard, N.
    Dalle, J. -H.
    Ruggeri, A.
    Gluckman, E.
    Milpied, N.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S11 - S12
  • [45] REDUCED-INTENSITY CONDITIONING (RIC) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) FOR PATIENTS AGED ≥60 YEARS: A RETROSPECTIVE ANALYSIS OF 629 PATIENTS FROM THE SOCIETE FRANCAISE DE GREFFE DE MOELLE ET DE THERAPIE CELLULAIRE (SFGM-TC)
    Mohty, M.
    Blaise, D.
    Milpied, N.
    Michallet, M.
    Vernant, J. P.
    Fegueux, N.
    Guilhot, F.
    Rio, B.
    Gratecos, N.
    Cahn, J. Y.
    Socie, G.
    Yakoub-Agha, I
    Huynh, A.
    Francois, S.
    Bay, J. O.
    Cordonnier, C.
    Buzyn, A.
    Contentin, N.
    Deconinck, E.
    Chevallier, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S162 - S162
  • [46] Impact of hematopoietic stem cell (HSC) recruitment and graft composition on transplant outcome after reduced intensity allogeneic peripheral blood stem cell transplantation (PBSCT): A study of the Societe Francaise de Greffe de Moelle Osseuse et de Therapie Cellulaire (SFGM-TC) registry.
    Prebet, T
    Le, QH
    Boiron, JM
    Blaise, D
    Huynh, A
    Yakoub-Agha, I
    Esperou, N
    Garban, F
    Bourhis, JH
    Michallet, M
    BLOOD, 2005, 106 (11) : 334A - 334A
  • [47] Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Societe rancaise de Greffe de Moelle Osseuse et Therapie Cellulaire and Eurocord
    Nguyen, S.
    Achour, A.
    Souchet, L.
    Vigouroux, S.
    Chevallier, P.
    Furst, S.
    Sirvent, A.
    Bay, J-O
    Socie, G.
    Ceballos, P.
    Huynh, A.
    Cornillon, J.
    Francois, S.
    Legrand, F.
    Yakoub-Agha, I.
    Michel, G.
    Maillard, N.
    Margueritte, G.
    Maury, S.
    Uzunov, M.
    Bulabois, C-E
    Michallet, M.
    Clement, L.
    Dauriac, C.
    Bilger, K.
    Lejeune, J.
    Beziat, V.
    Rocha, V.
    Rio, B.
    Chevret, S.
    Vieillard, V.
    BONE MARROW TRANSPLANTATION, 2017, 52 (10) : 1428 - 1435
  • [48] Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Societe Francophone de Greffe de Moelle et de Therapie cellulaire (SFGM-TC) multicentre cohort study
    Xhaard, Alienor
    Xhaard, Constance
    D'Aveni, Maud
    Salvator, Helene
    Chabi, Marie-Laure
    Berceanu, Ana
    Coman, Tereza
    Beguin, Yves
    Chalandon, Yves
    Poire, Xavier
    Loschi, Michael
    Paillard, Catherine
    Bruno, Benedicte
    Ceballos, Patrice
    Dalle, Jean-Hugues
    Bilger, Karin
    Bay, Jacques-Olivier
    Robin, Marie
    N'Guyen-Quoc, Stephanie
    Rubio, Marie-Therese
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (05) : E121 - E124
  • [49] Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myelome (IFM) and the Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC)
    Mohty, M
    Attal, M
    Marit, G
    Bulabois, CE
    Garban, F
    Gratecos, N
    Rio, B
    Vernant, JP
    Sotto, JJ
    Cahn, JY
    Blaise, D
    Jouet, JP
    Facon, T
    Yakoub-Agha, I
    BONE MARROW TRANSPLANTATION, 2005, 35 (02) : 165 - 169
  • [50] Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients Aged ≥60 Years: a Retrospective Study of 629 Patients From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC)
    Chevallier, Patrice
    Blaise, Didier
    Milpied, Noel-Jean
    Michallet, Mauricette
    Vernant, Jean-Paul
    Fegueux, Nathalie
    Renaud, Marc
    Rio, Bernard
    Gratecos, Nicole
    Cahn, Jean-Yves
    Socie, Gerard
    Yakoub-Agha, Ibrahim
    Huynh, Anne
    Francois, Sylvie
    Bay, Jacques-Olivier
    Cordonnier, Catherine
    Buzyn, Agnes
    Contentin, Nathalie
    Deconinck, Eric
    Mohty, Mohamad
    BLOOD, 2009, 114 (22) : 84 - 85
12345